Palisade Bio announces $3.9M warrant exercise; issues new warrants for up to 8.6M shares

PALISADE BIO, INC.

Existing warrant holders exercised 4,318,905 shares at reduced price $0.9047 (from $1.40); gross proceeds ~$3.9M.
Holders receive new unregistered warrants to purchase up to 8,637,810 shares at $0.9047, 5-year term, exercisable after stockholder approval.
Company to seek stockholder approval within 60 days; new warrants include cashless exercise after 6 months if registration not effective.
Pays placement agent Ladenburg Thalmann 8% cash fee plus 6% warrants; net proceeds for working capital.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.